Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Geranylgeranylacetone induces apoptosis via mitochondrial pathway in human melanoma cells
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Myo-Kyoung | - |
| dc.contributor.author | Jo, Aj-Reum | - |
| dc.contributor.author | Jeong, Hyo-Soon | - |
| dc.contributor.author | Yun, Hey-Young | - |
| dc.contributor.author | Baek, Kwang-Jin | - |
| dc.contributor.author | Kwon, Nyoun-Soo | - |
| dc.contributor.author | Kim, Dong-Seok | - |
| dc.date.accessioned | 2021-11-11T00:40:14Z | - |
| dc.date.available | 2021-11-11T00:40:14Z | - |
| dc.date.issued | 2015-11 | - |
| dc.identifier.issn | 0277-0008 | - |
| dc.identifier.issn | 1875-9114 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/51291 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | WILEY-BLACKWELL | - |
| dc.title | Geranylgeranylacetone induces apoptosis via mitochondrial pathway in human melanoma cells | - |
| dc.type | Article | - |
| dc.identifier.bibliographicCitation | PHARMACOTHERAPY, v.35, no.11, pp E321 - E321 | - |
| dc.description.isOpenAccess | N | - |
| dc.identifier.wosid | 000366045000471 | - |
| dc.citation.endPage | E321 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | E321 | - |
| dc.citation.title | PHARMACOTHERAPY | - |
| dc.citation.volume | 35 | - |
| dc.type.docType | Meeting Abstract | - |
| dc.publisher.location | 미국 | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.